Are milieus like Vision Zero Cancer a good way to accelerate innovation? At Stockholm School of Economics, doctoral student John-Erik Bergkvist is researching this – the methodology for building a vision-driven innovation milieu.

More and more patients need radiotherapy. But radiation therapy treatment is an area where research in Sweden has gone from leading to lagging behind internationally. How do we reverse the trend? How do we ensure that radiation therapy research continues to develop and become even better so that more patients survive and can live a better life with less side effects?

To transform cancer from a deadly to a curable or chronic disease it is crucial to improve the precision in cancer treatment and follow-up of individual patients' cancer disease. The Partnership for Precision Medicine in Cancer and Vision Zero Cancer are joining forces to accelerate research into precision medicine, with the aim to benefit every cancer patient.

Fourteen. That's how many times, Mia Rajalin visited primary care before she received the chest X-ray that showed the tumor. And the X-ray referral was sent with hesitation – she was too young and had never smoked a cigarette.

The Lung Cancer Association wants to change lung cancer care. Especially in the case of early detection, where many other countries have already introduced tools and methods to support healthcare. But in Sweden it takes too long, says Karin Liljelund, the association's vice chairman. And lung cancer does not wait.

With national cancer care programs, standardized care processes and accessibility initiatives, cancer control in Sweden has come a long way in recent years. Now the focus will be on research and innovation. Among other things, through Vision Zero Cancer.

Lung cancer is one of the cancers where the fewest patients survive. In Sweden, every year, nearly 4,000 people are diagnosed. Almost as many die. Therefore, innovations in cancer control can make a big difference.